Ostfold Hospital Trust

5 trials 3 recruiting Academic / non-commercial Merged from 2 name variants

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

3 Recruiting

0 Completed trials

2 Countries active

6 Unique IMPs

N/A Results reported

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 2 Phase IV: 1

Oversight events:

3 serious breaches 1 corrective measure across 2 trials

View oversight register →

Top indications

Major depression 2 Deep vein thrombosis 1 Pulmonary embolism 1 Post procedural pulmonary embolism 1 Venous thrombosis 1 Deep vein thrombosis postoperative 1 Pulmonary venous thrombosis 1

Top IMPs

METHYLENEDIOXYMETHAMPHETAMINE 1 SEMAGLUTIDE 1

All trials

5 total

A Randomized, Delayed-Treatment Controlled, Phase 2 Pilot Study of Manualized MDMA-Assisted Therapy for Young Adults with Chronic Treatment-… Pending

2024-520319-42-01 Phase II 1 country METHYLENEDIOXYMETHAMPHETAMINE
Ketamine maintenance treatment for depression: A multicenter open-label randomized controlled trial (PreKET) Pending

2025-521330-29-00 Phase II 1 country
Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) – a Pragmatic Randomized Controlled Tri… Recruiting

2023-505573-32-00 Phase III 1 country
eHealth Based treatment of AdolescenT obesiTy with Low energy diet and sEmaglutide (eBATTLE Obesity) Recruiting

2023-506289-29-00 Phase IV 1 country SEMAGLUTIDE
StAtins for Venous Event Reduction in Patients with Venous Thromboembolism : The SAVER Trial Recruiting

2023-504486-23-00 Phase III 2 countries

Showing 1–5 of 5 trials

← All sponsors A–Z